Published in Lab Invest on December 01, 1992
Identification of autoantibody clusters that best predict lupus disease activity using glomerular proteome arrays. J Clin Invest (2005) 2.36
Selective Memory to Apoptotic Cell-Derived Self-Antigens with Implications for Systemic Lupus Erythematosus Development. J Immunol (2016) 1.37
Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis. Am J Pathol (1995) 0.78
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82
Anionic sites in the glomerular basement membrane. In vivo and in vitro localization to the laminae rarae by cationic probes. J Cell Biol (1979) 4.14
Presence of heparan sulfate in the glomerular basement membrane. Proc Natl Acad Sci U S A (1979) 3.82
Increased permeability of the glomerular basement membrane to ferritin after removal of glycosaminoglycans (heparan sulfate) by enzyme digestion. J Cell Biol (1980) 2.75
Isolation of glycosaminoglycans (heparan sulfate) from glomerular basement membranes. Proc Natl Acad Sci U S A (1979) 2.28
Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum (2001) 2.28
Synovial fluid-derived mesenchymal stem cells increase after intra-articular ligament injury in humans. Rheumatology (Oxford) (2008) 2.11
Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion. J Neurosci Methods (1997) 2.04
Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol (2001) 1.99
Identification of a receptor for protein import into chloroplasts and its localization to envelope contact zones. Nature (1988) 1.87
Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology (Oxford) (2005) 1.81
Fibronectin localization in the rat glomerulus. J Cell Biol (1980) 1.80
Assembly of the glomerular filtration surface. Differentiation of anionic sites in glomerular capillaries of newborn rat kidney. J Cell Biol (1980) 1.75
Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin. J Biol Chem (1997) 1.73
Takayasu's arteritis associated with ulcerative colitis; genetic factors in this association. Intern Med (1996) 1.72
Oxidative stress in diabetic nephropathy. Curr Med Chem (2010) 1.70
Flow cytometric single-cell analysis of cytokine production by CD4+ T cells in synovial tissue and peripheral blood from patients with rheumatoid arthritis. Arthritis Rheum (1998) 1.69
Partial characterization of newly synthesized proteoglycans isolated from the glomerular basement membrane. J Cell Biol (1981) 1.66
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes. Diabetologia (2011) 1.63
The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis. Arthritis Rheum (1997) 1.60
Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum (1999) 1.60
Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci U S A (1995) 1.56
Neurological deficits in the presence of the sinking skin flap following decompressive craniectomy. Neurol Med Chir (Tokyo) (1977) 1.55
Effects of olmesartan on renal and cardiovascular outcomes in type 2 diabetes with overt nephropathy: a multicentre, randomised, placebo-controlled study. Diabetologia (2011) 1.53
Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis (2010) 1.52
Renal interstitial fibrosis is reduced in angiotensin II type 1a receptor-deficient mice. J Am Soc Nephrol (2001) 1.46
The effect of antimicrobial periodontal treatment on circulating tumor necrosis factor-alpha and glycated hemoglobin level in patients with type 2 diabetes. J Periodontol (2001) 1.45
Biophysiology of glomerular filtration and proteinuria. Lab Invest (1984) 1.45
Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. J Clin Invest (1997) 1.44
Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR. J Biol Chem (2000) 1.42
Increased expression of intercellular adhesion molecule-1 (ICAM-1) in diabetic rat glomeruli: glomerular hyperfiltration is a potential mechanism of ICAM-1 upregulation. Diabetes (1997) 1.40
Decreased de novo synthesis of glomerular proteoglycans in diabetes: biochemical and autoradiographic evidence. Proc Natl Acad Sci U S A (1983) 1.35
Familial occurrence of moya-moya disease: report of three Japanese families. J Neurol Neurosurg Psychiatry (1979) 1.34
Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset. Diabetologia (2009) 1.33
Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J Biol Chem (2001) 1.32
In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology (1993) 1.30
Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol (2003) 1.27
Direct interaction of insulin-like growth factor-1 receptor with leukemia-associated RhoGEF. J Cell Biol (2001) 1.26
Oxidative stress is reduced by the long-term use of vitamin E-coated dialysis filters. Kidney Int (2001) 1.25
Detachment of endothelium and epithelium from the glomerular basement membrane produced by kidney perfusion with neuraminidase. Lab Invest (1980) 1.25
Early changes in gene expression that influence the course of primary glomerular disease. Kidney Int (2007) 1.25
Malignant hypertension with a rare complication of pulmonary alveolar hemorrhage. Am J Nephrol (2000) 1.21
Canine model of obstructive sleep apnea: model description and preliminary application. J Appl Physiol (1985) (1994) 1.19
cDNA-derived primary structure of the glycoprotein component of canine microsomal signal peptidase complex. J Biol Chem (1988) 1.19
Altered glomerular permeability as a result of focal detachment of the visceral epithelium. Kidney Int (1982) 1.19
Morphologic studies in a patient with homocystinuria due to 5, 10-methylenetetrahydrofolate reductase deficiency. Pediatr Res (1976) 1.19
The role of an epithelial neutrophil-activating peptide-78-like protein in rat adjuvant-induced arthritis. J Immunol (1999) 1.18
Functional variants of interleukin-23 receptor gene confer risk for rheumatoid arthritis but not for systemic sclerosis. Ann Rheum Dis (2007) 1.16
Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus. Diabetologia (2005) 1.16
Human diabetes associated with a deletion of the tyrosine kinase domain of the insulin receptor. Science (1989) 1.15
Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane. J Immunol (1996) 1.15
Risk factors for lymph node metastasis in histologically poorly differentiated type early gastric cancer. Endoscopy (2009) 1.13
Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol (1994) 1.13
Pseudoalteromonas bacteriolytica sp. nov., a marine bacterium that is the causative agent of red spot disease of Laminaria japonica. Int J Syst Bacteriol (1998) 1.11
Prognostic significance of FTO genotype in the development of obesity in Japanese: the J-SHIPP study. Int J Obes (Lond) (2009) 1.11
Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin. Lab Invest (1982) 1.10
Nephritogenicity of antibodies to proteoglycans of the glomerular basement membrane--I. J Clin Invest (1986) 1.10
Distribution of de novo synthesized sulfated glycosaminoglycans in the glomerular basement membrane and mesangial matrix. Lab Invest (1983) 1.10
Screening methods for early detection of hepatocellular carcinoma. Hepatology (1985) 1.09
Characterization of heparan sulfate-proteoglycan of glomerular basement membranes. Proc Natl Acad Sci U S A (1984) 1.09
Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease. Acta Neuropathol (1994) 1.09
Interferon-gamma-inducing activity of interleukin-18 in the joint with rheumatoid arthritis. Arthritis Rheum (2001) 1.09
Pseudomalabsorption of levothyroxine: a case report. Endocr J (2000) 1.08
Role of connective tissue growth factor in profibrotic action of transforming growth factor-beta: a potential target for preventing renal fibrosis. Am J Kidney Dis (2001) 1.07
Characterization of mammalian translocase of inner mitochondrial membrane (Tim44) isolated from diabetic newborn mouse kidney. Proc Natl Acad Sci U S A (1998) 1.06
Expression of interleukin-12 in synovial tissue from patients with rheumatoid arthritis. Arthritis Rheum (1998) 1.05
Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia (1998) 1.05
Identification of genes specifically expressed in the accumulated visceral adipose tissue of OLETF rats. J Lipid Res (2000) 1.05
Effects of chronic inhibition of ACE and AT1 receptors on glomerular injury in dahl salt-sensitive rats. Am J Physiol (1998) 1.05
Role of macrophages in the pathogenesis of diabetic nephropathy. Contrib Nephrol (2001) 1.05
Chronic pancreatitis with diffuse irregular narrowing of the main pancreatic duct. Dig Dis Sci (1998) 1.04
Salmonellosis associated with abdominal aortic aneurysm. Arch Intern Med (1974) 1.04
Cloning of rat fibrillin-2 cDNA and its role in branching morphogenesis of embryonic lung. Dev Biol (1999) 1.04
Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. Biochem Biophys Res Commun (1989) 1.03
Retinal complications with elevated circulating plasma C5a associated with interferon-alpha therapy for chronic active hepatitis C. Am J Gastroenterol (1994) 1.03
A membranous nephropathy associated with adult polycystic kidney disease. Clin Nephrol (1991) 1.03
Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy. Nephron (1998) 1.02
Comparative role of phosphotyrosine kinase domains of c-ros and c-ret protooncogenes in metanephric development with respect to growth factors and matrix morphogens. Dev Biol (1996) 1.02
Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications. Rheumatology (Oxford) (2007) 1.02
Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy. Diabetologia (1998) 1.02
Biology of polycystic kidney disease. Lab Invest (1994) 1.01
Assessment of the developmental totipotency of neural cells in the cerebral cortex of mouse embryo by nuclear transfer. Proc Natl Acad Sci U S A (2001) 1.01
Fulminant type 1 diabetes as a high risk group for diabetic microangiopathy--a nationwide 5-year-study in Japan. Diabetologia (2007) 1.00
Distribution of sulfated glycosaminoglycans in the glomerular basement membrane and mesangial matrix. Eur J Cell Biol (1983) 1.00
Inhibition of shock-elicited ultrasonic vocalization by opioid peptides in the rat: a psychotropic effect. Psychoneuroendocrinology (1986) 1.00
Gene expression profile in streptozotocin-induced diabetic mice kidneys undergoing glomerulosclerosis. Kidney Int (2001) 1.00
Antiphospholipid antibodies in acute coronary syndrome. Lupus (2004) 1.00
Survival and causes of death in 366 Hungarian patients with systemic sclerosis. Ann Rheum Dis (2007) 1.00
[General pharmacology of cefoperazone, a new cephalosporin antibiotic (author's transl)]. Jpn J Antibiot (1980) 1.00
Identification of a renal-specific oxido-reductase in newborn diabetic mice. Proc Natl Acad Sci U S A (2000) 0.99
Structure/function studies of human beta-cell glucokinase. Enzymatic properties of a sequence polymorphism, mutations associated with diabetes, and other site-directed mutants. J Biol Chem (1993) 0.99
Pharmacological profile of AA-861, a 5-lipoxygenase inhibitor. Prostaglandins (1983) 0.99
Cyclin D1 overexpression as a prognostic factor in patients with esophageal carcinoma. J Surg Oncol (2001) 0.99
Cervical cancer screening in Japan. A case-control study. Acta Cytol (1997) 0.98
Determination of bisphenol a in effluents of hemodialyzers. Nephron (2001) 0.98